Article
Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
Carcinogenesis - 1 Jul 2010
Blomquist Thomas M, Crawford Erin L, Willey James C
Abstract excerpt
ERCC5 (XPG) is a key component of the nucleotide excision DNA repair pathway. In two recent case-control studies, we determined that ERCC5 transcript expression pattern in grossly normal human bronchial epithelial cells (NBEC) was different in individuals diagnosed with lung cancer compared with non-lung cancer controls. In this study, we tested the hypothesis that variation at cis-acting sites contributed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
